| GSM2981839 |
tumor from IDB-01 TNBC PDX model resistant to docetaxel (Q24_1_41) |
| GSM2981840 |
tumor from IDB-01 TNBC PDX model resistant to docetaxel (Q24_11_45) |
| GSM2981841 |
tumor from IDB-02 TNBC PDX model sensitive to docetaxel (13_5_59) |
| GSM2981842 |
tumor from IDB-02 TNBC PDX model sensitive to docetaxel (13_5_60) |
| GSM2981843 |
tumor from IDB-02 TNBC PDX model resistant to docetaxel (Q13_5_34) |
| GSM2981844 |
tumor from IDB-02 TNBC PDX model resistant to docetaxel (Q13_5_38) |
| GSM2981845 |
tumor from IDB-02 TNBC PDX model resistant to docetaxel (Q1305_39) |
| GSM2981846 |
tumor from IDB-03 luminal PDX model resistant but not treated with docetaxel (1070_79) |
| GSM2981847 |
tumor from IDB-03 luminal PDX model resistant but not treated with docetaxel (1070_81) |
| GSM2981848 |
tumor from IDB-03 luminal PDX model resistant and treated with docetaxel (Q1070_19) |
| GSM2981849 |
tumor from IDB-03 luminal PDX model resistant and treated with docetaxel (Q1070_22) |
| GSM2981850 |
tumor from IDB-04 luminal PDX model resistant but not treated with docetaxel (25_5_29) |
| GSM2981851 |
tumor from IDB-04 luminal PDX model resistant but not treated with docetaxel (25_5_31) |
| GSM2981852 |
tumor from IDB-04 luminal PDX model resistant and treated with docetaxel (Q25_5_23) |
| GSM2981853 |
tumor from IDB-04 luminal PDX model resistant and treated with docetaxel (Q25_5_26) |
| GSM2981854 |
tumor from IDB-05 triple-positive PDX model (956_7) |
| GSM2981855 |
tumor from IDB-05 triple-positive PDX model (956_14) |
| GSM3791791 |
Human origin tumor from IDB-01 (Pleural effusion) (24_11_PL) |
| GSM3791792 |
Human origin tumor from IDB-02 (Pleural effusion) (13_5_PL) |
| GSM3791793 |
Human origin tumor from IDB-03 (primary tumor) (1070_PT) |
| GSM3791794 |
Human origin tumor from IDB-04 (Pleural effusion) (25_5_PL) |
| GSM3791795 |
Tumor from VHIO-127 TNBC PDX model resistant to docetaxel (VHIO-127R1) |
| GSM3791796 |
Tumor from VHIO-127 TNBC PDX model sensitive to docetaxel (VHIO-127S1) |
| GSM3791797 |
Tumor from VHIO-127 TNBC PDX model resistant to docetaxel (VHIO-127R2) |
| GSM3791798 |
Tumor from VHIO-127 TNBC PDX model sensitive to docetaxel (VHIO-127S2) |
| GSM3791799 |
Tumor from IDB-02 TNBC PDX model resistant to docetaxel (IDB-02R1) |
| GSM3791800 |
Tumor from IDB-02 TNBC PDX model sensitive to docetaxel (IDB-02S1) |
| GSM3791801 |
Tumor from IDB-02 TNBC PDX model resistant to docetaxel (IDB-02R2) |
| GSM3791802 |
Tumor from IDB-02 TNBC PDX model sensitive to docetaxel (IDB-02S2) |
| GSM3791803 |
Tumor from IDB-01 TNBC PDX model resistant to docetaxel (IDB-01R1) |
| GSM3791804 |
Tumor from IDB-01 TNBC PDX model sensitive to docetaxel (IDB-01S1) |
| GSM3791805 |
Tumor from IDB-01 TNBC PDX model resistant to docetaxel (IDB-01R2) |
| GSM3791806 |
Tumor from IDB-01 TNBC PDX model resistant to docetaxel (IDB-01S2) |
| GSM3791807 |
Tumor from IDB-01 TNBC PDX model residual disease to docetaxel (IDB-01RD1) |
| GSM3791808 |
Tumor from IDB-01 TNBC PDX model residual disease to docetaxel (IDB-01RD2) |
| GSM3791809 |
Tumor from IDB-02 TNBC PDX model residual disease to docetaxel (IDB-02RD1) |
| GSM3791810 |
Tumor from IDB-02 TNBC PDX model residual disease to docetaxel (IDB-02RD2) |
| GSM3791811 |
Tumor from VHIO-127 TNBC PDX model residual disease to docetaxel (VHIO-127RD1) |
| GSM3791812 |
Tumor from VHIO-127 TNBC PDX model residual disease to docetaxel (VHIO-127RD2) |
| GSM3791813 |
Tumor from VHIO-98 TNBC PDX model sensitive to docetaxel (VHIO-98S1) |
| GSM3791814 |
Tumor from VHIO-98 TNBC PDX model sensitive to docetaxel (VHIO-98S2) |
| GSM3791815 |
Tumor from VHIO-98 TNBC PDX model residual disease to docetaxel (VHIO-98RD1) |
| GSM3791816 |
Tumor from VHIO-98 TNBC PDX model residual disease to docetaxel (VHIO-98RD2) |
| GSM3791817 |
Tumor from VHIO-98 TNBC PDX model resistant to docetaxel (VHIO-98R1) |
| GSM3791818 |
Tumor from VHIO-98 TNBC PDX model resistant to docetaxel (VHIO-98R2) |
| GSM3791819 |
Tumor from IDB-09 TNBC PDX model residual disease to docetaxel (IDB-09RD2) |
| GSM3791820 |
Tumor from IDB-09 TNBC PDX model sensitive to docetaxel (IDB-09S2) |
| GSM3791821 |
Tumor from IDB-09 TNBC PDX model residual disease to docetaxel (IDB-09RD1) |
| GSM3791822 |
Tumor from IDB-09 TNBC PDX model sensitive to docetaxel (IDB-09S1) |
| GSM3791823 |
Tumor from IDB-09 TNBC PDX model resistant to docetaxel (IDB-09R1) |
| GSM3791824 |
Tumor from IDB-09 TNBC PDX model resistant to docetaxel (IDB-09R2) |
| GSM3791825 |
Tumor from HCI-001 TNBC PDX model sensitive to docetaxel (HCI-001S1) |
| GSM3791826 |
Tumor from HCI-001 TNBC PDX model sensitive to docetaxel (HCI-001S2) |
| GSM3791827 |
Tumor from HCI-001 TNBC PDX model residual disease to docetaxel (HCI-001RD1) |
| GSM3791828 |
Tumor from HCI-001 TNBC PDX model residual disease to docetaxel (HCI-001RD2) |
| GSM3791829 |
Tumor from VHIO-270 TNBC PDX model sensitive to docetaxel (VHIO-270S1) |
| GSM3791830 |
Tumor from VHIO-270 TNBC PDX model sensitive to docetaxel (VHIO-270S2) |
| GSM3791831 |
Tumor from VHIO-270 TNBC PDX model residual disease to docetaxel (VHIO-270RD1) |
| GSM3791832 |
Tumor from VHIO-270 TNBC PDX model residual disease to docetaxel (VHIO-270RD2) |
| GSM3791833 |
Tumor from BCM-4664 TNBC PDX model sensitive to docetaxel (BCM-4664S1) |
| GSM3791834 |
Tumor from BCM-4664 TNBC PDX model senstive to docetaxel (BCM-4664S2) |
| GSM3791835 |
Tumor from BCM-4664 TNBC PDX model residual disease to docetaxel (BCM-4664RD1) |
| GSM3791836 |
Tumor from BCM-4664 TNBC PDX model residual disease to docetaxel (BCM-4664RD2) |
| GSM3791837 |
Tumor from BCM-4664 TNBC PDX model sensitive to docetaxel (BCM-9161S1) |
| GSM3791838 |
Tumor from BCM-9161 TNBC PDX model sensitive to docetaxel (BCM-9161S2) |
| GSM3791839 |
Tumor from BCM-9161 TNBC PDX model residual disease to docetaxel (BCM-9161RD1) |
| GSM3791840 |
Tumor from BCM-9161 TNBC PDX model residual disease to docetaxel (BCM-9161RD2) |
Less...
More...